Chuanchao He

Department of Hepatobiliary Surgery, Sun Yat-sen University

Affiliated withSun Yat-sen University

Research Area

Biography

Chuanchao He has not added Biography.
If you are Chuanchao He and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2025

Other Publications

Article	Year
High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma. Human pathology\| PubMed ID: 22406368	2012
Comparison of duct-to-mucosa and end-to-side pancreaticojejunostomy reconstruction following pancreaticoduodenectomy. Hepato-gastroenterology\| PubMed ID: 22773303	2013
Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib. Cancer letters\| PubMed ID: 25034398	2014
Regulation mechanism of Fbxw7-related signaling pathways (Review). Oncology reports\| PubMed ID: 26324296	2015
Treatment strategy for huge hepatocellular carcinoma with intrahepatic metastasis and macrovascular invasion: a case report and literature review. Journal of cancer research and therapeutics\| PubMed ID: 30539879	2018
ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR\| PubMed ID: 30646949	2019
A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways. Molecular therapy. Nucleic acids\| PubMed ID: 31128422	2019
Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma. Hepatology international\| PubMed ID: 31802389	2020
Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma. The Indian journal of surgery\| PubMed ID: 32288384	2018
Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma. Cancer cell international\| PubMed ID: 32368186	2020
PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK. Theranostics\| PubMed ID: 32929353	2020
Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression. Oncogene\| PubMed ID: 33051595	2021
INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR\| PubMed ID: 34996491	2022
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study. Journal of gastrointestinal oncology\| PubMed ID: 35557567	2022
Circular RNA circSFMBT2 downregulation by HBx promotes hepatocellular carcinoma metastasis via the miR-665/TIMP3 axis. Molecular therapy. Nucleic acids\| PubMed ID: 36159591	2022
SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression. Cancer science\| PubMed ID: 38438251	2024
Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 38472558	2024
mA-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism. Advanced science (Weinheim, Baden-Wurttemberg, Germany)\| PubMed ID: 40801445	2025